Piramal Pharma Limited Announces Consolidated Results for Q4 and FY2023

MUMBAI, India, May 24, 2023 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the fourth quarter (Q4) and full year FY23 ended 31st March 2023. Consolidated Financial Highlights (In INR Crores) Particulars Quarterly Full Year Q4 FY23 Q4 FY22 YoYGrowth Q3 FY23 QoQGrowth FY23 FY22 YoYGrowth Revenue from … Read more